Literature DB >> 19383251

Microvessel density and expression of thrombospondin-1 in non-small cell lung cancer and their correlation with clinicopathological features.

Z J Chen1, H B Le, Y K Zhang, L Y Qian, W D Li.   

Abstract

Microvessel density and thrombospondin-1 (TSP-1) expression were analysed in 42 non-small cell lung cancer (NSCLC) specimens and 40 normal lung tissue specimens using immunohistochemistry. Microvessel density was significantly higher and TSP-1 expression significantly lower in NSCLC tissue compared with normal tissue. Significantly lower levels of TSP-1 expression and higher microvessel densities were found in late-stage NSCLC compared with early-stage NSCLC, and in those with lymph node metastasis compared with those without metastasis. A statistically significant inverse correlation was observed between TSP-1 expression and microvessel density in squamous cell carcinoma but not in adenocarcinoma. These results suggest a close relationship between microvessel density and NSCLC tumour progress, and that a high expression of TSP-1 may play an important role in inhibiting tumour occurrence and development. The lack of correlation between microvessel density and TSP-1 expression in adenocarcinoma suggests that the mechanism of tumour inhibition by TSP-1 varies according to histological type.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383251     DOI: 10.1177/147323000903700232

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  8 in total

Review 1.  Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Authors:  Jessica C Sieren; Yoshiharu Ohno; Hisanobu Koyama; Kazuro Sugimura; Geoffrey McLennan
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

Review 2.  Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer.

Authors:  Giorgio Scagliotti; Ramaswamy Govindan
Journal:  Oncologist       Date:  2010-04-28

3.  Protein signature of lung cancer tissues.

Authors:  Michael R Mehan; Deborah Ayers; Derek Thirstrup; Wei Xiong; Rachel M Ostroff; Edward N Brody; Jeffrey J Walker; Larry Gold; Thale C Jarvis; Nebojsa Janjic; Geoffrey S Baird; Sheri K Wilcox
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 4.  Bevacizumab in the treatment of NSCLC: patient selection and perspectives.

Authors:  Alessia E Russo; Domenico Priolo; Giovanna Antonelli; Massimo Libra; James A McCubrey; Francesco Ferraù
Journal:  Lung Cancer (Auckl)       Date:  2017-12-14

5.  Cloning, Expression and Inhibitory Effects on Lewis Lung Carcinoma Cells of rAj-Tspin from Sea Cucumber (Apostichopus japonicus).

Authors:  Rong Qiao; Rong Xiao; Zhong Chen; Jingwei Jiang; Chenghua Yuan; Shuxiang Ning; Jihong Wang; Zunchun Zhou
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

6.  MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.

Authors:  Xiang Tan; Mingwu Chen
Journal:  Tumour Biol       Date:  2014-09-02

7.  Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.

Authors:  Tzu-Yang Weng; Chih-Yang Wang; Yu-Hsuan Hung; Wei-Ching Chen; Yi-Ling Chen; Ming-Derg Lai
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

8.  [Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer].

Authors:  Xuanxuan Zheng; Huijuan Wang; Guowei Zhang; Xiangtao Yan; Zhiyong Ma
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.